Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

December 15, 2025

Study Completion Date

February 15, 2026

Conditions

Liver Transplant; Complications

Interventions

DRUG

Dexmedetomidine

dexmedetomidine infusion rule in prevention of IRI

DRUG

Normal Saline

normal saline infusion as a placebo

Trial Locations (1)

Assiut University, Asyut

All Listed Sponsors

lead

Assiut University

OTHER